Bin Zheng
Director/Board Member presso Beijing Sihuan Kebao Pharmaceutical Co., Ltd.
Profilo
Bin Zheng is an Independent Director who currently holds a position at Beijing Sihuan Kebao Pharmaceutical Co., Ltd.
He previously held the same position at Nations Technologies, Inc., ENC Digital Technology Co. Ltd., and Tibet Aim Pharm., Inc.
Posizioni attive di Bin Zheng
Società | Posizione | Inizio |
---|---|---|
Beijing Sihuan Kebao Pharmaceutical Co., Ltd.
Beijing Sihuan Kebao Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Sihuan Kebao Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical preparations. Its products include nicorandil for injection, terbutaline sulfate for injection, troxerutin for injection, aminomethylbenzoic acid for injection, isosorbide dinitrate for injection, and olopatadine hydrochloride tablets. The company was founded on December 4, 1998 and is headquartered in Beijing, China. | Director/Board Member | 01/12/2021 |
Precedenti posizioni note di Bin Zheng
Società | Posizione | Fine |
---|---|---|
TIBET AIM PHARM. INC. | Director/Board Member | - |
ENC DIGITAL TECHNOLOGY CO., LTD | Director/Board Member | - |
NATIONS TECHNOLOGIES INC. | Director/Board Member | - |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
NATIONS TECHNOLOGIES INC. | Electronic Technology |
TIBET AIM PHARM. INC. | Health Technology |
ENC DIGITAL TECHNOLOGY CO., LTD | Technology Services |
Aziende private | 1 |
---|---|
Beijing Sihuan Kebao Pharmaceutical Co., Ltd.
Beijing Sihuan Kebao Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Sihuan Kebao Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical preparations. Its products include nicorandil for injection, terbutaline sulfate for injection, troxerutin for injection, aminomethylbenzoic acid for injection, isosorbide dinitrate for injection, and olopatadine hydrochloride tablets. The company was founded on December 4, 1998 and is headquartered in Beijing, China. | Health Technology |
- Borsa valori
- Insiders
- Bin Zheng